Your browser is no longer supported. Please, upgrade your browser.
MNKD MannKind Corporation daily Stock Chart
MNKD [NASD]
MannKind Corporation
Index- P/E- EPS (ttm)-0.23 Insider Own0.30% Shs Outstand212.47M Perf Week12.69%
Market Cap320.83M Forward P/E- EPS next Y-0.12 Insider Trans3.15% Shs Float202.29M Perf Month8.63%
Income-46.30M PEG- EPS next Q-0.05 Inst Own24.70% Short Float16.45% Perf Quarter18.90%
Sales61.80M P/S5.19 EPS this Y56.00% Inst Trans-12.41% Short Ratio14.04 Perf Half Y32.46%
Book/sh-0.93 P/B- EPS next Y57.10% ROA-52.80% Target Price- Perf Year31.30%
Cash/sh0.18 P/C8.25 EPS next 5Y30.20% ROE24.10% 52W Range0.80 - 1.88 Perf YTD17.05%
Dividend- P/FCF- EPS past 5Y36.50% ROI57.40% 52W High-19.68% Beta2.15
Dividend %- Quick Ratio0.70 Sales past 5Y- Gross Margin51.60% 52W Low88.75% ATR0.09
Employees233 Current Ratio0.70 Sales Q/Q-6.90% Oper. Margin-56.10% RSI (14)67.81 Volatility8.07% 7.26%
OptionableYes Debt/Eq- EPS Q/Q44.70% Profit Margin-75.00% Rel Volume0.77 Prev Close1.49
ShortableYes LT Debt/Eq- EarningsMay 06 BMO Payout- Avg Volume2.37M Price1.51
Recom1.40 SMA2013.77% SMA5024.87% SMA20017.53% Volume1,818,951 Change1.34%
Dec-24-19Initiated Oppenheimer Outperform $2.50
Oct-25-19Initiated Cantor Fitzgerald Overweight $3
May-14-19Initiated BTIG Research Buy $3
Mar-04-19Initiated SVB Leerink Outperform $3
Feb-22-19Initiated SVB Leerink Outperform $3
Feb-28-18Downgrade Maxim Group Hold → Sell $1
Nov-01-17Downgrade Maxim Group Buy → Hold
Oct-10-17Initiated H.C. Wainwright Buy $7
Oct-06-17Reiterated Maxim Group Buy $4 → $7
Aug-11-17Initiated Maxim Group Buy $4
May-10-16Reiterated RBC Capital Mkts Underperform $0.15 → $0.20
May-10-16Reiterated Piper Jaffray Underweight $0.05 → $0.10
Jan-06-16Reiterated RBC Capital Mkts Underperform $1 → $0.15
Jan-06-16Reiterated Piper Jaffray Underweight $1.50 → $0.05
Nov-04-15Downgrade RBC Capital Mkts Outperform → Underperform $9 → $1
Sep-09-15Downgrade Piper Jaffray Neutral → Underweight
Aug-03-15Reiterated RBC Capital Mkts Outperform $10 → $9
May-11-15Reiterated MLV & Co Hold $7 → $4
May-11-15Downgrade JP Morgan Neutral → Underweight
Apr-16-15Reiterated RBC Capital Mkts Outperform $13 → $10
May-25-20 11:12AM  Introducing MannKind (NASDAQ:MNKD), The Stock That Tanked 94% Simply Wall St.
May-19-20 08:44PM  MannKind (MNKD) Stock Could Nearly Double in the Next Year, Says Analyst SmarterAnalyst
May-07-20 04:36AM  Edited Transcript of MNKD earnings conference call or presentation 6-May-20 9:00pm GMT Thomson Reuters StreetEvents
May-06-20 05:15PM  MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:00PM  MannKind Corporation Reports 2020 First Quarter Financial Results GlobeNewswire
Apr-29-20 05:00PM  MannKind Corporation to Hold 2020 First Quarter Financial Results Conference Call on May 6, 2020 GlobeNewswire
Apr-28-20 12:33PM  MannKind (MNKD) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-15-20 08:00AM  MannKind Receives Forgivable Loan under the Paycheck Protection Program GlobeNewswire
Mar-31-20 10:54AM  3 Penny Stocks With Triple-Digit Upside Potential TipRanks
Mar-24-20 09:00AM  Jennifer Grancio Appointed to MannKind Board of Directors GlobeNewswire +9.18%
Mar-17-20 09:00AM  MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic GlobeNewswire +24.78%
Mar-07-20 03:31AM  Edited Transcript of MNKD earnings conference call or presentation 25-Feb-20 2:00pm GMT Thomson Reuters StreetEvents
Feb-25-20 08:00AM  MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results GlobeNewswire -11.18%
Feb-24-20 06:25PM  MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-20-20 09:00AM  MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020) GlobeNewswire +5.59%
Feb-18-20 09:00AM  MannKind Corporation to Hold 2019 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2020 GlobeNewswire
Jan-22-20 09:22AM  Should You Worry About MannKind Corporation's (NASDAQ:MNKD) CEO Pay? Simply Wall St.
Jan-20-20 04:37AM  3 Top-Notch Strong Buy Stocks Under $3 TipRanks
Jan-10-20 05:00AM  Top Picks 2020- MannKind MNKD MoneyShow +5.59%
Jan-06-20 08:00AM  Afrezza® (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month GlobeNewswire
Dec-20-19 06:21PM  Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds? Insider Monkey
09:00AM  Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza® Relative to Insulin Aspart in Type 1 Diabetes GlobeNewswire
Nov-29-19 09:00AM  MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire
Nov-21-19 09:00AM  MannKind Appoints Tony Hooper to Its Board of Directors GlobeNewswire
Nov-16-19 09:39PM  Edited Transcript of MNKD earnings conference call or presentation 6-Nov-19 2:00pm GMT Thomson Reuters StreetEvents
Nov-12-19 02:26PM  Introducing MannKind (NASDAQ:MNKD), The Stock That Collapsed 96% Simply Wall St.
Nov-06-19 08:00AM  MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results GlobeNewswire -11.41%
Nov-04-19 09:00AM  MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics GlobeNewswire
Oct-30-19 09:00AM  MannKind Corporation to Hold 2019 Third Quarter Financial Results Conference Call on November 6, 2019 GlobeNewswire
Sep-26-19 09:00AM  MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-19-19 09:00AM  MannKind Presents Positive Afrezza® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD GlobeNewswire
Sep-12-19 11:25AM  United Therapeutics' Trevyent NDA for PAH Accepted by FDA Zacks
Sep-10-19 03:30PM  5 Dollar Stocks to Buy Now InvestorPlace +6.67%
10:10AM  MannKind (NASDAQ:MNKD) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Aug-30-19 09:00AM  MannKind Corporation to Present at H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire
Aug-23-19 12:00PM  MNKD: Q2 2019: Record Revenue, Margins as Rx Continue to Ramp. Clinical Evidence Driving Adoption Zacks Small Cap Research -5.41%
Aug-16-19 08:35AM  Edited Transcript of MNKD earnings conference call or presentation 7-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-08-19 11:23AM  MannKind Corporation (MNKD) Q2 2019 Earnings Call Transcript Motley Fool
Aug-07-19 04:01PM  MannKind Corporation Reports 2019 Second Quarter Financial Results and Recent Business Highlights GlobeNewswire
Aug-05-19 09:00AM  MannKind and One Drop Sign Collaboration Agreement to Integrate Bluetooth-Connected Inhaler with Dose Detection into the One Drop Platform GlobeNewswire -5.08%
Aug-01-19 05:02PM  MannKind Corporation to Hold 2019 Second Quarter Financial Results Conference Call on August 7, 2019 GlobeNewswire
Jul-31-19 09:00AM  Afrezza® Safety and Pharmacokinetics Study in Pediatric Patients Opens Enrollment for Cohort 3 GlobeNewswire
Jul-18-19 08:52AM  MannKind Repays Maturing Debt Obligation; Buys Back Certain Warrants GlobeNewswire
Jul-15-19 09:00AM  MannKind Partners with GoodRx to Help Raise Awareness on Reducing Out of Pocket Insulin Cost for Patients GlobeNewswire
Jul-11-19 04:14PM  MannKind Expands Commercial Scale Manufacturing Capabilities for High-Potency Molecules GlobeNewswire -5.26%
Jul-09-19 12:09PM  What Kind Of Shareholders Own MannKind Corporation (NASDAQ:MNKD)? Simply Wall St.
Jun-14-19 10:00AM  MNKD: ADA Presentations: Positive Pediatric Data Lends Support for Anticipated Pivotal Study. Adult Data Highlights Benefits, Safety of Higher Doses Zacks Small Cap Research
Jun-12-19 09:00AM  MannKind to Present at the JMP Securities Life Sciences Conference GlobeNewswire
Jun-09-19 02:00PM  MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific Sessions GlobeNewswire
Jun-03-19 08:00AM  Afrezza® (insulin human) Inhalation Powder Approved in Brazil GlobeNewswire +6.03%
May-18-19 08:03AM  2 Healthcare Stocks That Could Double Your Money Motley Fool
May-17-19 08:03AM  The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering Benzinga
May-16-19 04:01PM  MannKind Announces Afrezza® Distribution Agreement in Australia GlobeNewswire
May-14-19 03:47PM  Why MannKind Is Up Big Today Motley Fool +7.32%
10:00AM  MNKD: Product Sales Up 49% on 71% Growth in Demand. Product Margin Continues to Expand Zacks Small Cap Research
May-08-19 09:24AM  MannKind Corporation (MNKD) Q1 2019 Earnings Call Transcript Motley Fool -6.21%
May-07-19 05:53PM  Edited Transcript of MNKD earnings conference call or presentation 7-May-19 1:00pm GMT Thomson Reuters StreetEvents -6.45%
08:19AM  MannKind: 1Q Earnings Snapshot Associated Press
08:00AM  MannKind Corporation Reports 2019 First Quarter Financial Results GlobeNewswire
May-02-19 09:26AM  United Therapeutics (UTHR) Down Despite Q1 Earnings Beat Zacks
Apr-30-19 09:00AM  MannKind Corporation to Hold 2019 First Quarter Financial Results Conference Call on May 7, 2019 GlobeNewswire
Apr-25-19 09:45AM  MannKind Presents Scientific Data at 28th Annual Scientific and Clinical Congress of the American Association of Clinical Endocrinologists (AACE 2019) GlobeNewswire
Apr-02-19 06:00AM  MannKind to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire
Apr-01-19 06:00AM  MannKind Receives $12.5 Million Milestone Payment from United Therapeutics GlobeNewswire -8.63%
Mar-14-19 09:00AM  MannKind to Sponsor Andretti Autosport Type 1 Diabetes Driver, Conor Daly GlobeNewswire +6.16%
Mar-13-19 03:00PM  These Four Healthcare Stocks Are Making Moves on Wednesday ACCESSWIRE
Mar-06-19 01:09PM  Edited Transcript of MNKD earnings conference call or presentation 26-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
Mar-05-19 10:55AM  MNKD: A Head Start to 2019; Q4 and Annual 2018 Earnings Results Zacks Small Cap Research +5.23%
Feb-26-19 05:55PM  MannKind Corp (MNKD) Q4 2018 Earnings Conference Call Transcript Motley Fool +16.56%
04:43PM  Here's Why MannKind Rocketed Higher Today Motley Fool
08:00AM  MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call GlobeNewswire
07:00AM  MannKind Corporation to Host Earnings Call ACCESSWIRE
Feb-25-19 01:28PM  Q4 Earnings Outlook For MannKind Benzinga
Feb-21-19 07:32AM  The Daily Biotech Pulse: Genomic Health Earnings, AbbVie's Humira Approved For Another Indication In Japan Benzinga
Feb-20-19 05:00PM  MannKind Presents New Scientific Data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019) GlobeNewswire
09:00AM  MannKind Corporation Participating at Upcoming Conferences GlobeNewswire
Feb-19-19 04:31PM  MannKind Corporation to Hold 2018 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2019 GlobeNewswire
Feb-05-19 10:24AM  Weekly CFO Buys Highlight GuruFocus.com
08:00AM  Market Trends Toward New Normal in MannKind, IDEX, Belden, Bright Horizons Family Solutions, Masonite International, and Veritiv Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-21-19 10:45AM  MNKD: Update From Our Meeting With MNKD at JPM Zacks Small Cap Research
09:00AM  Biotech Stocks on the Move ACCESSWIRE
Jan-17-19 05:14AM  How to spot risky biotech companies and six to avoid now MarketWatch
Jan-16-19 04:30PM  MannKind Announces Direct Purchase Insulin Program Providing Afrezza® for as low as $4 a Day GlobeNewswire
Dec-27-18 08:00AM  MannKind Corporation to Hold Investor Conference Call GlobeNewswire
Dec-20-18 12:11PM  How Many MannKind Corporation (NASDAQ:MNKD) Shares Do Institutions Own? Simply Wall St. -32.54%
10:20AM  Why MannKind Stock Is Plunging Today Motley Fool
07:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and MannKind ACCESSWIRE
Dec-19-18 11:57PM  MannKind Announces Pricing of $40 Million Public Offering GlobeNewswire
04:01PM  MannKind Announces Commencement of Public Offering GlobeNewswire
Dec-11-18 10:00AM  MNKD: Zacks SCR Initiates Coverage of MannKind With $4.25/share Price Target Zacks Small Cap Research
Dec-10-18 11:00AM  Biotech Stocks Beating the Market ACCESSWIRE
Nov-27-18 09:00AM  MannKind Appoints Christine Mundkur to its Board of Directors GlobeNewswire
05:00AM  Analysts: Why United Therapeutics has had a streak of licensing deals American City Business Journals
Nov-16-18 05:48PM  Edited Transcript of MNKD earnings conference call or presentation 1-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
Nov-01-18 09:33AM  MannKind: 3Q Earnings Snapshot Associated Press
08:00AM  MannKind Corporation Reports 2018 Third Quarter Financial Results GlobeNewswire
Oct-31-18 02:46PM  United Therapeutics Corp (UTHR) Q3 2018 Earnings Conference Call Transcript Motley Fool
Oct-25-18 05:00PM  MannKind Corporation to Hold 2018 Third Quarter Financial Results Conference Call on November 1, 2018 GlobeNewswire
Oct-24-18 07:20AM  Research Report Identifies Cato, Roadrunner Transportation, Talend S.A, Vi, MannKind, and Acceleron Pharma with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Oct-17-18 08:00AM  Todays Research Reports on Stocks to Watch: Altimmune and MannKind ACCESSWIRE
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tross Stuart AChief People & Workpl OfficerJan 31Buy0.955,0004,750124,741Feb 03 09:17 PM
McCauley PatrickChief Commercial OfficerJan 31Buy0.955,0004,750100,433Feb 03 09:16 PM
Kendall David MChief Medical OfficerJan 31Buy0.952,3042,18952,154Feb 03 09:15 PM
Castagna MichaelChief Executive OfficerJan 31Buy0.955,0004,750168,560Feb 03 09:14 PM
Binder Steven B.Chief Financial OfficerJan 31Buy0.952,1682,06048,204Feb 03 09:14 PM
Tross Stuart AChief People & Workpl OfficerJul 31Buy0.955,0004,750121,785Jul 31 08:47 PM
Kendall David MChief Medical OfficerJul 31Buy0.955,0004,75049,850Jul 31 08:44 PM
McCauley PatrickChief Commercial OfficerJul 31Buy0.955,0004,75095,433Jul 31 08:44 PM
Barton CourtneyChief Compl & Privacy OfficerJul 31Buy0.954,0113,81029,584Jul 31 08:43 PM
Binder Steven B.Chief Financial OfficerJul 31Buy0.952,1392,03246,036Jul 31 08:40 PM
Castagna MichaelChief Executive OfficerJul 31Buy0.955,0004,750163,560Jul 31 08:41 PM